Sponsor or institution

Clinical trials and research at New York Medical College

• 20Clinical trials
• 29NIH research projects
• 2Countries

Newest trials

All recruiting trials (20)

• Targeted ablation to block scar channels that cause ventricular tachycardia

  This study tests whether targeted radiofrequency ablation of scar-channel exits can prevent ventricular tachycardia in patients with scarred hearts.

  Recruiting New York Medical College · Valhalla, New York · NCT07814079

• Family-donor viral CTLs plus standard care vs standard care alone for refractory ADV or CMV infection after stem cell transplant

  This study tests whether using family-donor virus-specific CTLs in addition to usual treatment helps children, teens, and young adults with hard-to-treat CMV or adenovirus infections after a stem cell transplant.

  Recruiting Phase 3 New York Medical College · Valhalla, New York and 1 other locations · NCT07225972

• Nivolumab plus chemotherapy for ALK+ relapsed/refractory ALCL in kids, teens, and young adults

  This trial tests whether adding nivolumab to chemotherapy, followed by reduced-dose chemoimmunotherapy and a stem cell transplant, can improve outcomes for young patients with relapsed or refractory ALK-positive ALCL.

  Recruiting Phase 2 New York Medical College · Valhalla, New York · NCT07013565

• Increasing doses of defibrotide for treating sinusoidal obstruction syndrome after transplant

  This study is testing whether higher doses of defibrotide can help people with sinusoidal obstruction syndrome after a transplant who haven't improved with standard doses.

  Recruiting Phase 2 New York Medical College · Vallhala, New York · NCT05987124

• Treatment for newborns with congenital CMV infection using immune cells

  This study is testing if adding immune cells to standard antiviral treatment can help newborns with congenital CMV infection get better.

  Recruiting at 4 sites Phase 2 New York Medical College · Los Angeles, California and 3 other locations · NCT05564598

• Combining targeted immunotherapy with chemotherapy for pediatric lymphoma

  This study is testing if adding a new type of immunotherapy to lower doses of chemotherapy can help children and young adults with certain types of lymphoma while keeping them safe.

  Recruiting at 2 sites Phase 2 New York Medical College · Birmingham, Alabama and 2 other locations · NCT05253495

• Targeted immunotherapy for high-risk T-cell leukemia and lymphoma in young patients

  This study is testing a new treatment called daratumumab for young patients with high-risk T-cell leukemia and lymphoma to see if it is safe and helps improve their outcomes after a stem cell transplant.

  Recruiting at 8 sites Phase 1 New York Medical College · Phoeniz, Arizona and 15 other locations · NCT04972942

• Using donor-derived T cells to treat mild to moderate COVID-19

  This study is testing whether T cells from family members who have recovered from COVID-19 can help treat hospitalized patients with mild to moderate COVID-19.

  Recruiting Phase 1/2 New York Medical College · Valhalla, New York and 3 other locations · NCT04896606

• Using stem cell transplant and Polatuzumab Vedotin for treating B-cell lymphomas

  This study is testing if a stem cell transplant followed by a new drug called Polatuzumab Vedotin can help people with different types of B-cell lymphomas feel better.

  Recruiting Phase 1/2 New York Medical College · Valhalla, New York · NCT04491370

• High dose Rituximab for newly diagnosed acute immune thrombocytopenic purpura

  This study is testing if a higher dose of Rituximab can help people with newly diagnosed acute immune thrombocytopenic purpura feel better and reduce the chances of their condition coming back.

  Recruiting Phase 1 New York Medical College · Vahalla, New York · NCT04323748

• Combining vorinostat with chemotherapy for relapsed solid tumors and CNS cancers

  This study is testing if adding a drug called vorinostat to chemotherapy can help people with relapsed solid tumors and brain cancers feel better and improve their treatment outcomes.

  Recruiting Phase 1 New York Medical College · Valhalla, New York · NCT04308330

• Using donor-derived T-cells to treat BK infections in patients with weakened immune systems

  This study is testing if special immune cells made from donors can help children and young adults with weak immune systems get rid of stubborn BK infections after a stem cell transplant.

  Recruiting at 7 sites Phase 1/2 New York Medical College · San Francisco, California and 6 other locations · NCT04197596

• Stem cell transplantation for blood disorders using specific cell depletion techniques

  This study is testing a new way of using stem cell transplants for children and young adults with blood disorders to see if removing certain cells helps them recover better and improve their quality of life.

  Recruiting Phase 2 New York Medical College · Valhalla, New York · NCT04099966

• Chemoimmunotherapy and stem cell transplant for NK T-cell leukemia and lymphoma

  This study is testing two different treatment combinations for people with advanced NK-cell leukemia and lymphoma to see which one works better before they receive a stem cell transplant.

  Recruiting at 6 sites Early Phase 1 New York Medical College · Birmingham, Alabama and 5 other locations · NCT03719105

• Using EBV-specific T-cells to treat difficult Epstein-Barr virus infections

  This study is testing a new treatment using specially made immune cells to help children and young adults who have tough Epstein-Barr virus infections after receiving organ transplants.

  Recruiting at 8 sites Phase 2 New York Medical College · Los Angeles, California and 7 other locations · NCT03266653

• Using virus-specific T-cells to treat CMV infections in young patients

  This study is testing a new treatment using special immune cells to help children and young adults with stubborn CMV infections after organ transplants when regular medicines haven’t worked.

  Recruiting at 9 sites Phase 2 New York Medical College · Los Angeles, California and 8 other locations · NCT03266640

• Using specialized T-cells to treat adenovirus infections in patients with immune deficiencies

  This study is testing whether special T-cells can help children, teens, and young adults with weak immune systems who have ongoing adenovirus infections after organ transplants.

  Recruiting at 9 sites Phase 2 New York Medical College · Los Angeles, California and 9 other locations · NCT03266627

• Using Defibrotide to Improve Stem Cell Transplant Outcomes for Sickle Cell Disease

  This study is testing if giving Defibrotide before a stem cell transplant can help people with sickle cell disease avoid serious complications and have better outcomes.

  Recruiting at 4 sites Phase 2 New York Medical College · Los Angeles, California and 3 other locations · NCT02675959

• Using obinutuzumab with chemotherapy for relapsed CD20+ Non-Hodgkin Lymphoma in young patients

  This study is testing if a new drug called obinutuzumab, alone or with chemotherapy, can help young patients with relapsed CD20 positive Non-Hodgkin Lymphoma feel better and improve their treatment results.

  Recruiting Phase 2 New York Medical College · Valhalla, New York · NCT02393157

• Registry for children with pulmonary hypertension

  This study is collecting information about children with pulmonary hypertension to better understand the condition and improve treatment options for them.

  Recruiting at 12 sites New York Medical College · Palo Alto, California and 13 other locations · NCT02249923

NIH-funded research (29)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Maternal donor immune cells plus standard antiviral therapy for newborn CMV infection

  A clinical trial tests whether giving newborns with congenital CMV infection maternal donor-derived immune cells along with valganciclovir helps the baby’s immune system fight CMV better than valganciclovir alone.

  NIH research New York Medical College · Valhalla, United States · NIH-11563793

• Modeling Lennox-Gastaut Syndrome to Improve Neurobehavioral Outcomes

  A research project at New York Medical College is studying Lennox-Gastaut syndrome to help reduce seizures and improve thinking and behavior in affected people.

  NIH research New York Medical College · Valhalla, United States · NIH-11416171

• Regulation of kidney potassium handling by Kir4.1 and Kir5.1

  This grant studies how kidney channels Kir4.1 and Kir5.1 influence potassium balance and how this affects heart and muscle health.

  NIH research New York Medical College · Valhalla, United States · NIH-11372982

• Tobacco Mosaic Virus as an intranasal vaccine platform against Pseudomonas infections

  A short, patient-friendly vaccine idea using a plant virus to help protect people at risk from Pseudomonas infections, especially in the lungs and after burns.

  NIH research New York Medical College · Valhalla, United States · NIH-11365083

• Targeted deep brain stimulation to reduce infantile epilepsy spasms

  This project will see if tiny electrical pulses delivered to specific deep brain areas can reduce severe infantile spasms, first in animal models to help design future treatments for babies.

  NIH research New York Medical College · Valhalla, United States · NIH-11354757

• How GPR75 affects obesity-linked heart and metabolism problems

  This project looks at whether targeting the protein GPR75 could help prevent heart and metabolism problems in people with obesity.

  NIH research New York Medical College · Valhalla, United States · NIH-11294176

• Mapping RNA regulation in human immune cells

  This study is looking at how certain RNA molecules work in your immune cells to help us understand diseases related to the immune system and metabolism, which could lead to better treatments for patients like you.

  NIH research New York Medical College · Valhalla, United States · NIH-11253113

• How a new form of the G6PD enzyme changes artery muscle cells

  This work looks at whether a newly found form of the G6PD enzyme in artery muscle cells affects artery stiffness and remodeling, especially in people with common G6PD gene variants.

  NIH research New York Medical College · Valhalla, United States · NIH-11232349

• How a protein affects kidney function and blood pressure regulation

  This study is looking at how a substance made in the kidneys called TNF affects blood pressure, especially when you eat salty foods, using special mice to learn more about how it works and how it might help us understand high blood pressure better.

  NIH research New York Medical College · Valhalla, United States · NIH-11144012

• Developing new treatments targeting a virus linked to certain cancers

  This study is looking for new medicines that can help people with illnesses caused by the Epstein-Barr Virus, like certain cancers and multiple sclerosis, by blocking a specific virus protein that makes these diseases worse.

  NIH research New York Medical College · Valhalla, United States · NIH-11140533

• How THC affects tiny cellular condensates in HIV infection

  A scientist team is studying how the drug THC might change small cellular structures and how this could impact HIV infection and related brain conditions.

  NIH research New York Medical College · Valhalla, United States · NIH-11139475

• Understanding how kidneys manage potassium for heart and muscle health

  This research explores how our kidneys control potassium levels in the body, which is vital for keeping our heart, muscles, and nerves working well.

  NIH research New York Medical College · Valhalla, United States · NIH-11137656

• Investigating how a specific enzyme affects lung cancer caused by airborne toxins

  This study is looking at how a specific protein related to DNA repair might play a role in lung cancer caused by harmful substances in the air, and it hopes to find new ways to help prevent or treat lung cancer for people affected by these environmental factors.

  NIH research New York Medical College · Valhalla, United States · NIH-11118840

• Investigating how potassium and sodium intake affects kidney function

  This study is looking at how certain proteins in your kidneys help manage potassium and sodium based on what you eat, so we can better understand how your diet affects kidney health over time.

  NIH research New York Medical College · Valhalla, United States · NIH-11113800

• Investigating how GPR75 affects obesity-related heart and metabolic issues

  This study is looking at how a specific protein called GPR75 affects health problems related to obesity, like heart disease and metabolic syndrome, to find new ways to help people with these conditions feel better.

  NIH research New York Medical College · Valhalla, United States · NIH-11037960

• Antibodies that protect against group A strep infections

  Researchers are looking for antibodies that stop group A streptococcus and testing whether antibodies from adults could protect children from infection.

  NIH research New York Medical College · Valhalla, United States · NIH-10999401

• How a new form of an enzyme affects blood vessel health

  This study is looking at a new form of an enzyme that helps keep your blood vessels healthy, especially for people with certain genetic traits, to see if it can help prevent problems like stiff arteries and other vascular issues.

  NIH research New York Medical College · Valhalla, United States · NIH-10983801

• Mother-derived CMV immune cells plus antiviral medicine for newborns with moderate-to-severe congenital CMV

  This looks at whether giving newborns their mother's CMV-fighting T cells together with the antiviral drug valganciclovir helps babies born with moderate-to-severe congenital CMV.

  NIH research New York Medical College · Valhalla, United States · NIH-10925352

• Understanding how sensory nerves affect insulin-producing cells in the pancreas

  This study is looking at how certain nerve cells help control insulin production in the pancreas, which is important for people with diabetes, and it hopes to find new ways to boost insulin secretion to help manage blood sugar levels better.

  NIH research New York Medical College · Valhalla, United States · NIH-10924026

• Investigating how SIN3a affects a key receptor in pulmonary arterial hypertension

  This study is looking at how a protein called SIN3a affects another protein, BMPR2, which is important for keeping your lung blood vessels healthy, and it hopes to find new ways to help people with pulmonary arterial hypertension (PAH) by understanding how these proteins work together.

  NIH research New York Medical College · Valhalla, United States · NIH-10914794

• Investigating how a specific protein affects cell growth beyond stress responses

  This study is looking at a special protein called HSF1 that helps keep our cells healthy and grow properly, using tiny worms to see how it works in different situations, which could help us understand both normal growth and how cancer develops.

  NIH research New York Medical College · Valhalla, United States · NIH-10914013

• How a protein affects kidney function and blood pressure regulation

  This study is looking at how a substance called TNF made in the kidneys affects blood pressure, especially when you eat salty foods, and it hopes to find new ways to help manage blood pressure for people who struggle with it.

  NIH research New York Medical College · Valhalla, United States · NIH-10908433

• How kidney channels regulate potassium levels in the body

  This study looks at how certain channels in your kidneys help keep your potassium levels balanced, which is important for heart health, especially if you have issues with potassium levels.

  NIH research New York Medical College · Valhalla, United States · NIH-10892924

• Investigating how delta-9-tetrahydrocannabinol affects cell structures in HIV infection.

  This study is looking at how a compound found in cannabis, THC, might help reduce inflammation and improve symptoms in people with HIV by affecting certain cell structures during the infection.

  NIH research New York Medical College · Valhalla, United States · NIH-10890889

• Identifying protective antibodies against group A streptococcal infections

  This study is looking at how certain antibodies can help protect against group A strep infections by finding out which parts of the bacteria trigger a strong immune response, and it’s for anyone interested in a potential new vaccine that could keep kids and adults safe from different strains of this infection.

  NIH research New York Medical College · Valhalla, United States · NIH-10747980

• How cannabinoids affect cell communication in HIV infection

  This study looks at how THC, a compound found in cannabis, affects tiny particles that help cells communicate in the body during HIV infection, and it's especially for people living with HIV who use cannabis to feel better.

  NIH research New York Medical College · Valhalla, United States · NIH-10693315

• Investigating how oxidative stress affects blood vessels and kidneys in adults born with low birth weight

  This study is looking at how being born with a low birth weight can lead to long-term health problems like high blood pressure and kidney disease, and it aims to find ways to reduce these risks and improve health for adults who experienced this.

  NIH research New York Medical College · Valhalla, United States · NIH-10530637

• Understanding how antibiotic resistance spreads in a common throat and skin infection.

  This study is looking into how certain germs that cause throat and skin infections can share their ability to resist antibiotics, which could help us find better ways to treat infections for people dealing with these tough bacteria.

  NIH research New York Medical College · Valhalla, United States · NIH-10474268

• Understanding how estrogen influences cell growth through mTOR signaling

  This study is looking at how estrogen affects cell growth and function, which is important for understanding diseases related to estrogen, and it aims to find out how estrogen activates a key pathway in our cells.

  NIH research New York Medical College · Valhalla, United States · NIH-10470830

Quick answers

How many clinical trials run by New York Medical College are recruiting right now?

20, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (20 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 10, Phase 1: 3, Phase 1/2: 3, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →